tradingkey.logo
tradingkey.logo
Search

Theriva Biologics Inc

TOVX
Add to Watchlist
0.211USD
+0.001+0.48%
Close 07-31 16:00ETQuotes delayed by 15 min
9.69MMarket Cap
LossP/E TTM

TOVX Financials

See Theriva Biologics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Theriva Biologics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-0.05/-0.05
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.08
89.07%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
96.80%-0.05
92.48%-0.12
93.38%-0.45
81.96%-1.93
79.36%-1.55
80.17%-1.59
-40.56%-6.81
-27.92%-10.72
-1.73%-7.53
9.34%-8.03
---4.85
---8.38
---7.40
---8.86
---22.37
----
----
----
----
----
Revenue
--300.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
52.73%-2.04M
21.16%-3.51M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
1.90%-5.49M
31.61%-3.30M
-2.33%-5.08M
-4.80%-4.48M
-6.23%-5.59M
-47.57%-4.83M
-55.49%-4.97M
62.71%-4.27M
-68.74%-5.26M
-21.85%-3.27M
3.82%-3.19M
Net Margin
---681.33%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-10.18%4.34%
944.14%4.52%
1265.33%5.55%
1193.77%4.73%
966.12%4.84%
6.21%0.43%
16.33%0.41%
8.78%0.37%
36.23%0.45%
5.33%0.41%
--0.35%
--0.34%
--0.33%
--0.39%
--0.32%
----
----
----
----
----
Revenue
--300.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
51.85%-2.13M
54.96%-2.06M
11.83%-4.44M
-197.10%-13.13M
18.08%-4.42M
16.98%-4.58M
-19.39%-5.04M
24.05%-4.42M
-4.13%-5.39M
-0.55%-5.52M
19.09%-4.22M
-29.28%-5.82M
-27.79%-5.18M
-4.22%-5.49M
-59.18%-5.21M
-40.82%-4.50M
-59.72%-4.05M
-146.95%-5.26M
-55.14%-3.27M
-10.66%-3.20M
Net Profit
52.73%-2.04M
21.16%-3.51M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
1.90%-5.49M
31.61%-3.30M
-2.33%-5.08M
-4.80%-4.48M
-6.23%-5.59M
-47.57%-4.83M
-55.49%-4.97M
62.71%-4.27M
-68.74%-5.26M
-21.85%-3.27M
3.82%-3.19M
Current assets
34.31%16.76M
7.28%17.47M
-49.30%9.90M
-25.22%14.74M
-42.39%12.48M
-40.59%16.28M
-43.82%19.53M
-48.07%19.71M
-46.26%21.66M
-39.80%27.40M
-34.07%34.77M
-30.83%37.97M
-32.33%40.30M
-33.89%45.52M
-28.31%52.73M
-27.43%54.89M
-24.26%59.55M
767.89%68.86M
1004.13%73.56M
744.48%75.63M
Total current liabilities
25.97%10.26M
32.02%10.01M
50.25%11.00M
80.99%12.39M
35.60%8.15M
12.57%7.58M
-16.24%7.32M
-25.03%6.85M
-30.28%6.01M
-4.56%6.74M
-33.72%8.74M
-31.14%9.13M
-21.47%8.62M
98.65%7.06M
317.47%13.19M
532.22%13.26M
417.25%10.98M
19.82%3.55M
4.98%3.16M
-38.82%2.10M
Total assets
18.93%38.25M
8.17%38.24M
-23.12%30.84M
-15.48%35.83M
-34.00%32.16M
-35.98%35.35M
-34.83%40.11M
-35.23%42.39M
-28.22%48.73M
-23.16%55.22M
-21.79%61.55M
-20.51%65.45M
-23.72%67.89M
2.13%71.86M
4.76%78.69M
6.57%82.33M
12.58%89.00M
736.68%70.36M
942.91%75.12M
706.25%77.25M
Total liabilities
37.12%22.85M
40.35%22.86M
55.74%24.10M
70.96%25.21M
14.08%16.66M
4.92%16.29M
-12.39%15.47M
-16.68%14.74M
-15.57%14.61M
-10.26%15.52M
-14.04%17.66M
-14.33%17.70M
-17.51%17.30M
248.94%17.30M
350.47%20.55M
486.18%20.66M
840.45%20.97M
57.27%4.96M
39.44%4.56M
-6.35%3.52M
Total equity
-0.63%15.40M
-19.32%15.38M
-72.65%6.74M
-61.57%10.62M
-54.58%15.50M
-51.97%19.07M
-43.86%24.64M
-42.11%27.65M
-32.54%34.12M
-27.25%39.70M
-24.53%43.88M
-22.57%47.75M
-25.64%50.59M
-16.58%54.56M
-17.59%58.15M
-16.35%61.67M
-11.45%68.03M
1143.97%65.41M
1694.51%70.56M
1167.07%73.73M
Net operating income
48.36%-2.46M
38.56%-2.88M
-10.38%-4.32M
-36.50%-4.71M
2.56%-4.76M
28.28%-4.69M
-32.51%-3.91M
11.31%-3.45M
12.99%-4.88M
-21.85%-6.54M
33.73%-2.95M
10.65%-3.89M
-14.44%-5.61M
-11.60%-5.37M
-106.68%-4.46M
-67.80%-4.36M
-47.30%-4.90M
-53.58%-4.81M
-5.17%-2.16M
-28.13%-2.60M
Net investment
--0.00
--0.00
---19.00K
-1500.00%-16.00K
--0.00
----
----
88.89%-1.00K
100.00%0.00
38.46%-56.00K
-1072.73%-129.00K
35.71%-9.00K
99.81%-8.00K
---91.00K
---11.00K
---14.00K
-30471.43%-4.28M
100.00%0.00
100.00%0.00
--0.00
Net financing
25.85%3.87M
120728.57%8.46M
-103.98%-148.00K
284.15%6.81M
--3.07M
100.48%7.00K
371500.00%3.72M
-16.99%1.77M
100.00%0.00
55.69%-1.46M
-99.96%1.00K
--2.14M
96.00%-55.00K
---3.29M
--2.73M
--0.00
-101.86%-1.38M
-100.00%0.00
--0.00
--0.00

FAQs

What are the current assets of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its current assets were 17.47M, with a year-on-year change of 7.28.

What are the total assets of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its total assets of Theriva Biologics Inc were 38.24M, with a year-on-year change of 8.17.

What are the total liabilities of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its total liabilities of Theriva Biologics Inc were 22.86M, with a year-on-year change of 40.35.

What is the total equity of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its total equity of Theriva Biologics Inc was 15.38M, with a year-on-year change of -19.32.

What is the net operating income of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its net operating income of Theriva Biologics Inc was -24.05M, with a year-on-year change of -23.80.

What is the net investment of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its net investment of Theriva Biologics Inc was -35.00K, with a year-on-year change of -3400.00.

What is the net financing of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its net financing of Theriva Biologics Inc was 18.19M, with a year-on-year change of 231.02.

What is the Earnings Per Share (EPS) of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.08, with a year-on-year change of 89.07.

What is the net income of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its net income was -25.25M, with a year-on-year change of 1.57.

What is the debt-to-asset ratio of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its debt-to-asset ratio was 4.52, with a year-on-year change of 944.14.

What is the Return on Equity (ROE) of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its Return on Equity (ROE) was -146.58, with a year-on-year change of -60.08.

What is the Return on Assets (ROA) of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its Return on Assets (ROA) was -64.52, with a year-on-year change of -13.89.

What is the operating profit of Theriva Biologics Inc?

According to Theriva Biologics Inc's FY2025 earnings report, its operating profit was -24.05M, with a year-on-year change of -23.80.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.